Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
Friday, June 4, 2010 - 18:41
in Health & Medicine
HOUSTON – When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with...